Skip to main content
LISATA THERAPEUTICS, INC. logo

LISATA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · LSTA ISIN · US1280583022 LEI · 5493002287F62M3EGQ04 US Manufacturing
Open in API
Filings indexed 1,093 across all filing types
Latest filing 2012-11-13 Regulatory Filings
Country US United States of America
Listing US LSTA

About LISATA THERAPEUTICS, INC.

https://www.lisata.com/

Lisata Therapeutics is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for advanced solid tumors and other major diseases. The company's core technology is the proprietary CendR Platform®, designed to enhance the targeted, tissue-penetrating delivery of anti-cancer drugs to solid tumors. The platform also aims to target non-cancerous, immunosuppressive cells within the tumor microenvironment, seeking to improve the efficacy of a patient's immune system and immunotherapies in fighting cancer.

Recent filings

Filing Released Lang Actions
S-8 POS
Regulatory Filings Classification · 100% confidence The document is a Post-Effective Amendment No. 1 to Form S-8 filed with the SEC by NeoStem, Inc. Form S-8 is a registration statement used for securities to be offered under employee benefit plans, specifically equity compensation plans. The text discusses amendments to the equity compensation plan, registration of shares for issuance under the plan, and references to SEC rules and filings. There is no financial performance data, earnings information, or management discussion. The document is a regulatory filing related to securities registration and amendments to such registration statements. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers miscellaneous SEC filings that do not fit other specific categories.
2012-11-13 English
10-Q
Interim / Quarterly Report Q3 2012
2012-11-13 English
OWNERSHIP DOCUMENT
Director's Dealing
2012-11-13 English
OWNERSHIP DOCUMENT
Director's Dealing
2012-10-26 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated October 25, 2012, by NeoStem, Inc. It reports the redemption of all outstanding shares of Series E Preferred Stock and the filing of a Certificate of Elimination with the Delaware Secretary of State. The document includes a press release and the Certificate of Elimination as exhibits. The content focuses on a corporate action related to capital structure (redemption and elimination of preferred stock). There are no financial statements or detailed financial analysis present, and the document is not an annual or quarterly report, nor a call transcript or management discussion. It is a regulatory filing reporting a specific corporate event. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length (6067 characters) and content confirm it is not a brief announcement but a formal regulatory filing. Confidence is high due to clear identification of the form and content.
2012-10-25 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated October 5, 2012, reporting the results of the NeoStem 2012 Annual Meeting. It includes detailed voting results on various proposals such as election of directors, approval of stock purchase plans, amendments to equity compensation plans, and other shareholder matters. The document also reports on the departure and election of directors and officers, and includes references to proxy statements and exhibits filed previously. The content focuses on the submission of matters to a vote of security holders and changes in board composition and compensatory arrangements. This matches the description of 'Declaration of Voting Results & Voting Rights Announcements (DVA)' as it provides official results from shareholder votes at the annual meeting. The document length is sufficient and contains substantive voting data, not just an announcement of a report. Therefore, the correct classification is DVA with high confidence.
2012-10-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.